Blog

FAST 5

J&J’s new psoriasis pill to challenge older biologics

Mar 23 2026

FAST 5

Could an FDA official’s exit spell regulatory relief for biotech?

Mar 20 2026

The Beghou Biopharma Review

Rep, regulatory shifts quicken pharma’s commercial evolution

Mar 19 2026

The Beghou Biopharma Review

Closing out 2025: AI's big leap and the search for organizational harmony

Mar 19 2026

The Beghou Biopharma Review

Dealing with dual demands: Tariffs, price caps create competing pressures for pharma marketers

Mar 19 2026

The Beghou Biopharma Review

From trade tensions to therapy pivots: What’s shaping pharma this summer

Mar 19 2026

The Beghou Biopharma Review

Launch radar: What 2026’s drug launches signal to commercial leaders; 4 questions for AbbVie’s Brent Hasko

Mar 19 2026

Webinar

Patient-centric commercialization in practice: Lessons from consumer-oriented and specialty Rx brands

Mar 17 2026

Article

Building a vendor strategy: Protecting commercial plans from supplier-driven data risk

Mar 10 2026

Beghou Voice

Top 2026 drug launches to watch: oral breakthroughs in obesity, psoriasis, and cholesterol

Feb 25 2026

Media Coverage

Taming the complexity of CGT commercialization: 5 keys to a workable operating model

Feb 23 2026

New Year, new pharma operating model: 2026 resolutions for life sciences commercialization

Jan 20 2026

2026 life sciences commercialization priorities: What’s funded, in the cart, and on the wish list

Dec 24 2025

Media Coverage

From chatbots to agents: How GPT-5 is reshaping healthcare and pharma

Nov 18 2025

Webinar

Webinar: Rethinking Life Sciences Commercialization for 2026: What’s Working, What’s Not and What’s Next

Nov 13 2025

The Beghou Biopharma Review

Research premiere for ‘Commercialization that Works’; direct channels reignite pharma’s patient-centricity hopes

Nov 13 2025